134 related articles for article (PubMed ID: 16053515)
1. Electrogene transfer of an Epstein-Barr virus-based plasmid replicon vector containing the diphtheria toxin A gene suppresses mammary carcinoma growth in SCID mice.
Shibata MA; Miwa Y; Miyashita M; Morimoto J; Abe H; Otsuki Y
Cancer Sci; 2005 Jul; 96(7):434-40. PubMed ID: 16053515
[TBL] [Abstract][Full Text] [Related]
2. Easy stable transfection of a human cancer cell line by electrogene transfer with an Epstein-Barr virus-based plasmid vector.
Shibata MA; Miwa Y; Morimoto J; Otsuki Y
Med Mol Morphol; 2007 Jun; 40(2):103-7. PubMed ID: 17572846
[TBL] [Abstract][Full Text] [Related]
3. Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation.
Shibata MA; Morimoto J; Otsuki Y
Cancer Gene Ther; 2002 Jan; 9(1):16-27. PubMed ID: 11916241
[TBL] [Abstract][Full Text] [Related]
4. Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes.
Saeki Y; Wataya-Kaneda M; Tanaka K; Kaneda Y
Gene Ther; 1998 Aug; 5(8):1031-7. PubMed ID: 10326025
[TBL] [Abstract][Full Text] [Related]
5. In vivo electrogene transfer of interleukin-12 inhibits tumor growth and lymph node and lung metastases in mouse mammary carcinomas.
Shibata MA; Ito Y; Morimoto J; Kusakabe K; Yoshinaka R; Otsuki Y
J Gene Med; 2006 Mar; 8(3):335-52. PubMed ID: 16345101
[TBL] [Abstract][Full Text] [Related]
6. Experimental gene therapy in mammary and urinary bladder cancer using electrogene transfer.
Shibata MA; Morimoto J; Ito Y; Kusakabe K; Otsuki Y
Med Electron Microsc; 2004 Dec; 37(4):216-24. PubMed ID: 15614446
[TBL] [Abstract][Full Text] [Related]
7. Electrogene therapy using endostatin, with or without suicide gene therapy, suppresses murine mammary tumor growth and metastasis.
Shibata MA; Morimoto J; Doi H; Morishima S; Naka M; Otsuki Y
Cancer Gene Ther; 2007 Mar; 14(3):268-78. PubMed ID: 17096028
[TBL] [Abstract][Full Text] [Related]
8. EBV replicon vector system enhances transgene expression in vivo: applications to cancer gene therapy.
Otomo T; Yamamoto S; Morishita R; Kaneda Y
J Gene Med; 2001; 3(4):345-52. PubMed ID: 11529664
[TBL] [Abstract][Full Text] [Related]
9. Improvement of nonviral gene therapy by Epstein-Barr virus (EBV)-based plasmid vectors.
Mazda O
Curr Gene Ther; 2002 Sep; 2(3):379-92. PubMed ID: 12189722
[TBL] [Abstract][Full Text] [Related]
10. Non-replicating Epstein-Barr virus-based plasmids extend gene expression and can improve gene therapy in vivo.
Tu G; Kirchmaier AL; Liggitt D; Liu Y; Liu S; Yu WH; Heath TD; Thor A; Debs RJ
J Biol Chem; 2000 Sep; 275(39):30408-16. PubMed ID: 10856307
[TBL] [Abstract][Full Text] [Related]
11. Prolonged transgene expression in glomeruli using an EBV replicon vector system combined with HVJ liposomes.
Tsujie M; Isaka Y; Nakamura H; Kaneda Y; Imai E; Hori M
Kidney Int; 2001 Apr; 59(4):1390-6. PubMed ID: 11260400
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S
Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
[TBL] [Abstract][Full Text] [Related]
13. Establishment and applications of epstein-barr virus-based episomal vectors in human embryonic stem cells.
Ren C; Zhao M; Yang X; Li D; Jiang X; Wang L; Shan W; Yang H; Zhou L; Zhou W; Zhang H
Stem Cells; 2006 May; 24(5):1338-47. PubMed ID: 16410388
[TBL] [Abstract][Full Text] [Related]
14. Polyethylenimine-mediated suicide gene transfer induces a therapeutic effect for hepatocellular carcinoma in vivo by using an Epstein-Barr virus-based plasmid vector.
Iwai M; Harada Y; Tanaka S; Muramatsu A; Mori T; Kashima K; Imanishi J; Mazda O
Biochem Biophys Res Commun; 2002 Feb; 291(1):48-54. PubMed ID: 11829460
[TBL] [Abstract][Full Text] [Related]
15. Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer.
Maruyama-Tabata H; Harada Y; Matsumura T; Satoh E; Cui F; Iwai M; Kita M; Hibi S; Imanishi J; Sawada T; Mazda O
Gene Ther; 2000 Jan; 7(1):53-60. PubMed ID: 10680016
[TBL] [Abstract][Full Text] [Related]
16. Molecular therapeutics of cancer by means of electroporation-based transfer of siRNAs and EBV-based expression vectors.
Mazda O; Kishida T
Front Biosci (Elite Ed); 2009 Jun; 1(1):316-31. PubMed ID: 19482649
[TBL] [Abstract][Full Text] [Related]
17. Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences.
Amit D; Hochberg A
J Transl Med; 2010 Dec; 8():134. PubMed ID: 21162716
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer in vitro and in vivo with Epstein-Barr virus-based episomal vector results in markedly high transient expression in rodent cells.
Tomiyasu K; Satoh E; Oda Y; Nishizaki K; Kondo M; Imanishi J; Mazda O
Biochem Biophys Res Commun; 1998 Dec; 253(3):733-8. PubMed ID: 9918796
[TBL] [Abstract][Full Text] [Related]
19. [Effect of recombinant adenovirus Ad-DT-A in targeted therapy for malignant cancer cell lines with loss of IGF2 imprinting].
Pan YQ; He BS; Zhu C; Qu LL; Xu XF; Wang SK
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):816-21. PubMed ID: 22335945
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus-1 tat- and tat/nef-defective genomes containing HIV-regulated diphtheria toxin A chain gene inhibit HIV replication.
Brdar B; Matulić M; Rubelj I; Ivanković M; Reich E
Croat Med J; 2002 Oct; 43(5):591-7. PubMed ID: 12402403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
